Option Care Health to buy Amedisys for $3.6B

Option Care Health, the nation’s largest independent provider of home and alternate site infusion services, is buying Amedisys, a leading home health, hospice and high-acuity care provider, for $3.6 billion.

Advertisement

The merger will “create a leading, independent platform for home and alternate site care,” according to a May 3 news release from Option. Together, the companies have a clinical workforce of more than 16,500 professionals across 674 care centers.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Post-Acute

Advertisement

Comments are closed.